Clinical trial NCT04736251 - References

Scar — Mechanistic Basis of Ablative Carbon Dioxide Laser in Treating Hypertrophic Scars

Citation(s)

•   Andrews N, Jones LL, Moiemen N, Calvert M, Kinghorn P, Litchfield I, Bishop J, Deeks JJ, Mathers J; PEGASUS Study Group
  Below the surface: Parents' views on the factors that influence treatment adherence in paediatric burn scar management - A qualitative study. Burns. 2018 May;44(3):626-635. doi: 10.1016/j.burns.2017.09.003. Epub 2017 Oct 12.
•   Browne RH
  On the use of a pilot sample for sample size determination. Stat Med. 1995 Sep 15;14(17):1933-40.
•   Brusselaers N, Pirayesh A, Hoeksema H, Verbelen J, Blot S, Monstrey S
  Burn scar assessment: A systematic review of objective scar assessment tools. Burns. 2010 Dec;36(8):1157-64. doi: 10.1016/j.burns.2010.03.016. Epub 2010 May 21. Review.
•   Coppé JP, Desprez PY, Krtolica A, Campisi J
  The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu Rev Pathol. 2010;5:99-118. doi: 10.1146/annurev-pathol-121808-102144. Review.
•   Demaria M, Ohtani N, Youssef SA, Rodier F, Toussaint W, Mitchell JR, Laberge RM, Vijg J, Van Steeg H, Dollé ME, Hoeijmakers JH, de Bruin A, Hara E, Campisi J
  An essential role for senescent cells in optimal wound healing through secretion of PDGF-AA. Dev Cell. 2014 Dec 22;31(6):722-33. doi: 10.1016/j.devcel.2014.11.012. Epub 2014 Dec 11.
•   Draaijers LJ, Tempelman FR, Botman YA, Tuinebreijer WE, Middelkoop E, Kreis RW, van Zuijlen PP
  The patient and observer scar assessment scale: a reliable and feasible tool for scar evaluation. Plast Reconstr Surg. 2004 Jun;113(7):1960-5; discussion 1966-7.
•   Gangemi EN, Gregori D, Berchialla P, Zingarelli E, Cairo M, Bollero D, Ganem J, Capocelli R, Cuccuru F, Cassano P, Risso D, Stella M
  Epidemiology and risk factors for pathologic scarring after burn wounds. Arch Facial Plast Surg. 2008 Mar-Apr;10(2):93-102. doi: 10.1001/archfaci.10.2.93.
•   Gauglitz GG, Korting HC, Pavicic T, Ruzicka T, Jeschke MG
  Hypertrophic scarring and keloids: pathomechanisms and current and emerging treatment strategies. Mol Med. 2011 Jan-Feb;17(1-2):113-25. doi: 10.2119/molmed.2009.00153. Epub 2010 Oct 5. Review.
•   Griffiths C, Guest E, White P, Gaskin E, Rumsey N, Pleat J, Harcourt D
  A Systematic Review of Patient-Reported Outcome Measures Used in Adult Burn Research. J Burn Care Res. 2017 Mar/Apr;38(2):e521-e545. doi: 10.1097/BCR.0000000000000474. Review.
•   Gunin AG, Kornilova NK, Petrov VV, Vasil'eva OV
  [Age-related changes in the number and proliferation of fibroblasts in the human skin]. Adv Gerontol. 2011;24(1):43-7. Russian.
•   Jones LL, Calvert M, Moiemen N, Deeks JJ, Bishop J, Kinghorn P, Mathers J; PEGASUS team
  Outcomes important to burns patients during scar management and how they compare to the concepts captured in burn-specific patient reported outcome measures. Burns. 2017 Dec;43(8):1682-1692. doi: 10.1016/j.burns.2017.09.004. Epub 2017 Oct 12.
•   Lancaster GA, Dodd S, Williamson PR
  Design and analysis of pilot studies: recommendations for good practice. J Eval Clin Pract. 2004 May;10(2):307-12.
•   Lee KC, Dretzke J, Grover L, Logan A, Moiemen N
  A systematic review of objective burn scar measurements. Burns Trauma. 2016 Apr 27;4:14. doi: 10.1186/s41038-016-0036-x. eCollection 2016. Review.
•   Manstein D, Herron GS, Sink RK, Tanner H, Anderson RR
  Fractional photothermolysis: a new concept for cutaneous remodeling using microscopic patterns of thermal injury. Lasers Surg Med. 2004;34(5):426-38.
•   Pallant JF, Tennant A
  An introduction to the Rasch measurement model: an example using the Hospital Anxiety and Depression Scale (HADS). Br J Clin Psychol. 2007 Mar;46(Pt 1):1-18.
•   Patrick DL, Burke LB, Powers JH, Scott JA, Rock EP, Dawisha S, O'Neill R, Kennedy DL
  Patient-reported outcomes to support medical product labeling claims: FDA perspective. Value Health. 2007 Nov-Dec;10 Suppl 2:S125-37. Review.
•   Rothman ML, Beltran P, Cappelleri JC, Lipscomb J, Teschendorf B; Mayo/FDA Patient-Reported Outcomes Consensus Meeting Group
  Patient-reported outcomes: conceptual issues. Value Health. 2007 Nov-Dec;10 Suppl 2:S66-75.
•   Shaw AC, Joshi S, Greenwood H, Panda A, Lord JM
  Aging of the innate immune system. Curr Opin Immunol. 2010 Aug;22(4):507-13. doi: 10.1016/j.coi.2010.05.003. Review.
•   Slemp AE, Kirschner RE
  Keloids and scars: a review of keloids and scars, their pathogenesis, risk factors, and management. Curr Opin Pediatr. 2006 Aug;18(4):396-402. Review.
•   Tyack Z, Kimble R, McPhail S, Plaza A, Simons M
  Psychometric properties of the Brisbane Burn Scar Impact Profile in adults with burn scars. PLoS One. 2017 Sep 13;12(9):e0184452. doi: 10.1371/journal.pone.0184452. eCollection 2017.
•   Zuccaro J, Ziolkowski N, Fish J
  A Systematic Review of the Effectiveness of Laser Therapy for Hypertrophic Burn Scars. Clin Plast Surg. 2017 Oct;44(4):767-779. doi: 10.1016/j.cps.2017.05.008. Epub 2017 Jul 10. Review.

A Prospective Intra-patient Single-blinded Randomised Trial to Examine the Mechanistic Basis of fractiOnal Ablative carbOn Dioxide Laser Therapy in Treating Adult Burns and/or Trauma Patients With Hypertrophic Scarring

Details for clinical trial NCT04736251